Abstract: otrA resembles elongation factor G (EF-G) and is considered to be an oxytetracycline (OTC)-resistance determinant in Streptomyces rimosus. In order to determine whether otrA also conferred resistance to OTC and other aminoglycosides to Streptomyces coelicolor, the otrA gene from S. rimosus M527 was cloned under the control of the strong ermE^* promoter. The resulting plasmid, pIB139-otrA, was introduced into S. coelicolor M145 by intergeneric conjugation, yielding the recombinant strain S. coelicolor M145-OA. As expected S. coelicolor M145-OA exhibited higher resistance levels specifically to OTC and aminoglycosides gentamycin, hygromycin, streptomycin, and spectinomycin. However, unexpectedly, S. coelicolor M145-OA on solid medium showed an accelerated aerial mycelia formation, a precocious sporulation, and an enhanced actinorhodin (Act) production. Upon growth in 5-L fermentor, the amount of intra- and extracellular Act production was 6-fold and 2-fold higher, respectively, than that of the original strain. Consistently, reverse transcription polymerase chain reaction (RT-PCR) analysis revealed that the transcriptional level of pathway-specific regulatory gene actII-orf4 was significantly enhanced in S. coelicolor M145-OA compared with in S. coelicolor M145.

天蓝色链霉菌M145中otrA基因的表达对菌株形态分化、放线紫红素合成及氨基糖苷类抗生素抗性的影响

[1]Baltz RH, 2016. Genetic manipulation of secondary metabolite biosynthesis for improved production in Streptomyces and other actinomycetes. J Ind Microbiol Biotechnol, 43(2-3):343-370.

[2]Binnie C, Warren M, Butler MJ, 1989. Cloning and heterologous expression in Streptomyces lividans of Streptomyces rimosus genes involved in oxytetracycline biosynthesis. J Bacteriol, 171(2):887-895.

[3]Blair JMA, Webber MA, Baylay AJ, et al., 2015. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol, 13(1):42-51.

[4]Borodina I, Siebring J, Zhang J, et al., 2008. Antibiotic overproduction in Streptomyces coelicolor A3(2) mediated by phosphofructokinase deletion. J Biol Chem, 283(37):25186-25199.

[5]Chandra G, Chater KF, 2014. Developmental biology of Streptomyces from the perspective of 100 actinobacterial genome sequences. FEMS Microbiol Rev, 38(3):345-379.

[6]Chater KF, Biró S, Lee KJ, et al., 2010. The complex extracellular biology of Streptomyces. FEMS Microbiol Rev, 34(2):171-198.

[7]Chen YH, Smanski MJ, Shen B, 2010. Improvement of secondary metabolite production in Streptomyces by manipulating pathway regulation. Appl Microbiol Biotechnol, 86(1):19-25.

[8]Chopra I, Roberts M, 2001. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev, 65(2):232-260.

[9]Chu XH, Zhen ZJ, Tang ZY, et al., 2012. Introduction of extra copy of oxytetracycline resistance gene otrB enhances the biosynthesis of oxytetracycline in Streptomyces rimosus. J Bioproces Biotech, 2:1000117.

[10]Coze F, Gilard F, Tcherkez G, et al., 2013. Carbon-flux distribution within Streptomyces coelicolor metabolism: a comparison between the actinorhodin-producing strain M145 and its non-producing derivative M1146. PLoS ONE, 8(12):e84151.

[11]Cundliffe E, Demain AL, 2010. Avoidance of suicide in antibiotic-producing microbes. J Ind Microbiol Biotechnol, 37(7):643-672.

[12]Doi Y, Arakawa Y, 2007. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis, 45(1):88-94.

[13]Doyle D, McDowall KJ, Butler MJ, et al., 1991. Characterization of an oxytetracycline-resistance gene, otrA, of Streptomyces rimosus. Mol Microbiol, 5(12):2923-2933.

[14]Guo MJ, Zheng ZJ, Yao GF, et al., 2012. Method for increasing oxytetracycline yield of Streptomyces rimosus. China Patent 201110107321:A.

[15]Hesketh A, Sun J, Bibb M, 2001. Induction of ppGpp synthesis in Streptomyces coelicolor A3(2) grown under conditions of nutritional sufficiency elicits actII-ORF4 transcription and actinorhodin biosynthesis. Mol Microbiol, 39(1):136-144.

[16]Hu SH, Yuan SX, Qu H, et al., 2016. Antibiotic resistance mechanisms of Myroides sp. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 17(3):188-199.

[17]Kieser T, Bibb MJ, Buttner MJ, et al., 2000. Practical Streptomyces Genetics. The John Innes Foundation, Norwich, UK.

[18]Lee SK, Mo SJ, Suh JW, 2012. An ABC transporter complex containing S-adenosylmethionine (SAM)-induced ATP-binding protein is involved in antibiotics production and SAM signaling in Streptomyces coelicolor M145. Biotechnol Lett, 34(10):1907-1914.

[19]Liu J, Li J, Dong H, et al., 2017. Characterization of an Lrp/AsnC family regulator SCO3361, controlling actinorhodin production and morphological development in Streptomyces coelicolor. Appl Microbiol Biotechnol, 101(14):5773-5783.

[20]Lu DD, Ma Z, Xu XH, et al., 2016. Isolation and identification of biocontrol agent Streptomyces rimosus M527 against Fusarium oxysporum f. sp. cucumerinum. J Basic Microbiol, 56(8):929-933.

[21]Ma Z, Luo S, Xu XH, et al., 2016. Characterization of representative rpoB gene mutations leading to a significant change in toyocamycin production of Streptomyces diastatochromogenes 1628. J Ind Microbiol Biotechnol, 43(4):463-471.

[22]Mak S, Xu Y, Nodwell JR, 2014. The expression of antibiotic resistance genes in antibiotic-producing bacteria. Mol Microbiol, 93(3):391-402.

[23]Malla S, Niraula NP, Liou K, et al., 2010. Self-resistance mechanism in Streptomyces peucetius: overexpression of drrA, drrB and drrC for doxorubicin enhancement. Microbiol Res, 165(4):259-267.

[24]Niu GQ, Chater KF, Tian YQ, et al., 2016. Specialised metabolites regulating antibiotic biosynthesis in Streptomyces spp. FEMS Microbiol Rev, 40(4):554-573.

[25]Petković H, Cullum J, Hranueli D, et al., 2006. Genetics of Streptomyces rimosus, the oxytetracycline producer. Microbiol Mol Biol Rev, 70(3):704-728.

[26]Pickens LB, Tang Y, 2010. Oxytetracycline biosynthesis. J Biol Chem, 285(36):27509-27515.

[27]Piddock LJV, 2006. Multidrug-resistance efflux pumps? Not just for resistance. Nat Rev Microbiol, 4(8):629-636.

[28]Prakash D, Nawani NN, 2014. A rapid and improved technique for scanning electron microscopy of actinomycetes. J Microbiol Methods, 99:54-57.

[29]Sambrook J, Russell DW, 2001. Molecular Cloning: A Laboratory Manual, 3rd Ed. Cold Spring Harbor Laboratory Press, New York, USA.

[30]Takano H, Nishiyama T, Amano SI, et al., 2016. Streptomyces metabolites in divergent microbial interactions. J Ind Microbiol Biotechnol, 43(2-3):143-148.

[31]Thaker M, Spanogiannopoulos P, Wright GD, 2010. The tetracycline resistome. Cell Mol Life Sci, 67(3):419-431.

[32]Wang GJ, Hosaka T, Ochi K, 2008. Dramatic activation of antibiotic production in Streptomyces coelicolor by cumulative drug resistance mutations. Appl Environ Microbiol, 74(9):2834-2840.

[33]Wang T, Bai LQ, Zhu DQ, et al., 2012. Enhancing macrolide production in Streptomyces by coexpressing three heterologous genes. Enzyme Microb Technol, 50(1):5-9.

[34]Xu XH, Wang J, Bechthold A, et al., 2017. Selection of an efficient promoter and its application in toyocamycin production improvement in Streptomyces diastatochromogenes 1628. World J Microbiol Biotechnol, 33(2):30.

[35]Yin SL, Wang XF, Shi MX, et al., 2017. Improvement of oxytetracycline production mediated via cooperation of resistance genes in Streptomyces rimosus. Sci China Life Sci, 60(9):992-999.

[36]Yu L, Yan XY, Wang L, et al., 2012. Molecular cloning and functional characterization of an ATP-binding cassette transporter OtrC from Streptomyces rimosus. BMC Biotechnol, 12:52.

[37]List of electronic supplementary materials

[38]Fig. S1 Phenotypic verification of seven randomly recombinant strains of S. coelicolor M145-OA

[39]Fig. S2 PCR analysis of otrA gene from S. coelicolor M145-OA

[40]Fig. S3 Morphological analyses of S. rimosus M527 and S. rimosus M527-OA on MS medium